Are We Able to Accurately Assess Post IPAA Pathology?

Overview

Journal Crohns Colitis 360

Publisher Oxford University Press

Date 2023 Feb 17

PMID 36798511

Authors

Amy L Lightner

Affiliations

Soon will be listed here.

Citing Articles

The Benefits and Drawbacks of Staging Pelvic Pouches.

Addison P, Keshinro A, Schwartzberg D Clin Colon Rectal Surg. 2023; 35(6):445-452.

PMID: 36591400 PMC: 9797283. DOI: 10.1055/s-0042-1758217.

References

Gregory M, Weaver K, Hoversten P, Hicks S, Patel D, Ciorba M . Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. Inflamm Bowel Dis. 2019; 25(9):1569-1576. PMC: 6939832. DOI: 10.1093/ibd/izz030. View

Lightner A, Mathis K, Dozois E, Hahnsloser D, Loftus Jr E, Raffals L . Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis. Inflamm Bowel Dis. 2017; 23(5):781-790. DOI: 10.1097/MIB.0000000000001061. View

Hahnloser D, Pemberton J, Wolff B, Larson D, Crownhart B, Dozois R . Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007; 94(3):333-40. DOI: 10.1002/bjs.5464. View

Huguet M, Pereira B, Goutte M, Goutorbe F, Dubois A, Bommelaer G . Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis. Inflamm Bowel Dis. 2018; 24(2):261-268. DOI: 10.1093/ibd/izx049. View

Barnes E, Raffals L, Long M, Syal G, Kayal M, Ananthakrishnan A . Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States. Crohns Colitis 360. 2020; 2(3):otaa039. PMC: 7380550. DOI: 10.1093/crocol/otaa039. View

Shelton E, Allegretti J, Stevens B, Lucci M, Khalili H, Nguyen D . Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis. 2015; 21(12):2879-85. PMC: 4745906. DOI: 10.1097/MIB.0000000000000561. View

Lightner A, Fletcher J, Pemberton J, Mathis K, Raffals L, Smyrk T . Crohn's Disease of the Pouch: A True Diagnosis or an Oversubscribed Diagnosis of Exclusion?. Dis Colon Rectum. 2017; 60(11):1201-1208. DOI: 10.1097/DCR.0000000000000918. View

Madiba T, Bartolo D . Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb. 2002; 46(6):334-7. View

Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T . Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg. 2003; 238(3):433-41. PMC: 1422709. DOI: 10.1097/01.sla.0000086658.60555.ea. View

10.

Weaver K, Gregory M, Syal G, Hoversten P, Hicks S, Patel D . Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort. Inflamm Bowel Dis. 2018; 25(4):767-774. DOI: 10.1093/ibd/izy302. View

11.

Ferrante M, Declerck S, Coopmans T, De Hertogh G, Van Assche G, Penninckx F . Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes. J Crohns Colitis. 2010; 2(2):142-51. DOI: 10.1016/j.crohns.2007.10.003. View

12.

Fazio V, Tekkis P, Remzi F, Lavery I, Manilich E, Connor J . Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003; 238(4):605-14. PMC: 1360119. DOI: 10.1097/01.sla.0000090940.39838.6a. View

13.

Shen B, Fazio V, Remzi F, Lashner B . Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol. 2006; 100(12):2796-807. DOI: 10.1111/j.1572-0241.2005.00278.x. View